Market Research Report
Insulin Patch Pumps
|Published by||Greystone Research Associates||Product code||223039|
Delivery time: 1-2 business days
|Insulin Patch Pumps|
|Published: November 9, 2011||Content info:||
This publication has been discontinued on July 3, 2017.
Greystone Research Associates is pleased to announce the publication of a new market study. Insulin Patch Pumps: Devices, Markets, Players and Prospects is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector.
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, treatment segments, and commercial opportunities for integrated devices that couple a transdermal drug device format with an active delivery technology. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
The collapse of the inhaled insulin market in 2008 has resulted in programs focused on alternative insulin delivery technologies. It now appears that the patch pump - a device that represents the convergence of a transdermal reservoir system with an energy source and control technology - will be the next generation in the evolution in patient-friendly insulin administration. With four FDA-approved insulin patch pump products and twice as many serious development-stage devices, the next 36 months will be critical to market sector participants wishing to ascend to a leadership position in the market segment. With no room for post-market missteps, product reliability, ease-of-use and patient acceptance will be essential for market success.
This report is available in electronic format.